Articles

Lilly reorganization to cut 5,500 positions over 2 years

Eli Lilly and Co. will cut 5,500 jobs by the end of 2011 as it tries to cut $1 billion in expenses before it loses revenue
from its bestselling drug, Zyprexa. Lilly CEO John Lechleiter said he did not know how many of those cuts would occur in central
Indiana. But with
13,600 employees working in the Indianapolis area, he acknowledged the largest chunk of reductions likely would come here.

Read More

Study weakens Lilly’s fight against price controls

Eli Lilly and Co. and its peers might be back in Congress’ sights as lawmakers hunt for more ways to cut health care
costs. A new study in the influential Health Affairs journal concludes that European drugmakers operating
in markets with pharmaceutical price controls have produced proportionally more innovations than their U.S. counterparts.

Read More

Lilly paid doctors to prescribe Zyprexa, notes say

Eli Lilly and Co. paid doctors in South Carolina for participating in a speakers’ program in exchange for prescribing the
antipsychotic Zyprexa, according to notes by Lilly sales representatives reviewed by Bloomberg News.

Read More

Hall-Render co-founder returns to law firm

A co-founder of Hall Render Killian Heath & Lyman PC is returning to the downtown law firm more than a decade after
he left it. Rex Killian will lead the firm’s governance consulting practice, which serves both not-for-profit
and for-profit health care clients.

Read More